BLSH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BLSH is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a mixed technical setup, weak latest-quarter financials, and the latest analyst action turned more cautious with a downgrade to Neutral. While the Equiniti acquisition is a meaningful strategic catalyst and options sentiment is bullish, the lack of a strong Intellectia buy signal and the deteriorating fundamental picture make this more of a hold than an immediate buy.
Price is 41.37, just above the 41.2 prior close, but the stock recently saw a -7.02% regular-session drop. MACD histogram is positive at 0.114 but contracting, which suggests momentum is weakening rather than strengthening. RSI_6 at 49.896 is neutral, and moving averages are converging, pointing to a flat-to-uncertain trend. Key levels show support at 37.088 and resistance at 46.691, with pivot near 41.89. Overall, the chart does not show a clear bullish breakout and the current trend is sideways to slightly fragile.
["Bullish announced a definitive agreement to acquire Equiniti for $4.2 billion, which is a major strategic expansion catalyst.", "The acquisition news triggered a strong stock reaction previously, showing the market sees potential strategic value.", "Options flow is constructive, with low put-call ratios suggesting bullish sentiment.", "No recent negative insider or hedge fund trading trends were identified."]
["Rosenblatt downgraded Bullish to Neutral from Buy and said the shares already reached its $39 target.", "The same downgrade highlighted valuation concerns, with the stock trading at a premium versus peers.", "Rosenblatt also warned that estimates are increasingly at risk due to collapsing crypto activity and weaker non-trading revenue support.", "Latest quarter financials were weak, with revenue down 2.55% YoY, net income sharply worse, EPS deeply negative, and gross margin declining.", "The stock recently posted a notable daily decline of -7.02%, showing near-term pressure."]
In Q4 2025, Bullish showed weakening fundamentals. Revenue fell 2.55% year over year to 64.35 billion, net income dropped to -546.6 million, EPS fell to -3.62, and gross margin declined to 3%. This is a poor latest-quarter earnings trend, with profitability worsening rather than improving. For a long-term beginner investor, this financial profile does not currently support an aggressive buy.
Analyst sentiment has turned mixed to cautious. Rosenblatt downgraded Bullish to Neutral from Buy on 2026-04-09, keeping a $39 target and citing stretched valuation and weakening estimates. Citi had earlier kept a Buy rating but trimmed its target from $67 to $65 and noted stalled legislative momentum in crypto regulation. Overall, Wall Street appears split, but the most recent move is a negative shift in tone. Pros: strategic M&A, potential market share expansion, and some support from bullish options sentiment. Cons: rich valuation, weak earnings trajectory, and pressure on crypto-related activity.
